Rhinovirus and the initiation of asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 9, Issue 1, 2009, Pages 73-78

  Gern, James E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Asthma; Children; Respiratory syncytial virus; Rhinovirus

Indexed keywords

ACTIVIN A; AMPHIREGULIN; FIBROBLAST GROWTH FACTOR; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

AGE DISTRIBUTION; ASTHMA; CLINICAL FEATURE; COMMON COLD; DISEASE ASSOCIATION; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN RHINOVIRUS; LOWER RESPIRATORY TRACT INFECTION; LUNG DEVELOPMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHINOVIRUS INFECTION; RISK FACTOR; VIRAL RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION; WHEEZING;

ASTHMA; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; PICORNAVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS; RHINOVIRUS;

EID: 58849112561     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32831f8f1b     Document Type: Review

References (61)

1. Kistler A, Avila PC, Rouskin S, et al. Pan-viral screening of respiratory tractinfections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 2007; 196: 817-825. This study describes a chip-based microarray that was used to explore the virology associated with acute exacerbations of asthma.
2. Lee WM, Grindle KA, Pappas TE,et al. A high-throughput, sensitive and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. J Clin Microbiol 2007; 45:2626-2634. This is an example of a high-throughput molecular test for all common respiratory viruses that can be used in large-scale observational studies.
3. Lamson D, Renwick N, Kapoor V, et al. MassTag polymerase-chain- reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005. J Infect Dis 2006; 194:1398-1402.
4. Lemanske RF Jr, Jackson DJ, Gangnon RE, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005; 116:571-577.
5. Miller EK, Lu X, Erdman DD, et al. Rhinovirus-associated hospitalizations in young children. J Infect Dis 2007; 195: 773-781. This is an excellent population-based study that used molecular and traditional techniques to identify respiratory pathogens in hospitalized children. There were high rates of viral detection, and rhinoviruses were shown to be associated with high rates of illness in infants and children with asthma.
6. Kusel MM, de Klerk NH, Holt PG, et al. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J 2006; 25: 680-686.
7. Regamey N, Kaiser L. Rhinovirus infections in infants: is respiratory syncytial virus ready for the challenge? Eur Respir J 2008; 32:249-251.
8. Lee WM, Kiesner C, Pappas T, et al. A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS ONE 2007; 2:e966. This study summarizes the identification of over 20 previously unknown strains of HRV, including a number of putative HRV C group viruses.
9. Kistler AL, Webster DR, Rouskin S, et-al. Genome-wide diversity and selective pressure in the human rhinovirus. Virol J 2007; 4:40. Microarray technology was used to evaluate the overall genetic structure of a large number of HRV strains and identify areas that are conserved versus hypervariable in the genomes.
10. McErlean P, Shackelton LA, Andrews E, et al. Distinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C). PLoS ONE 2008; 3: e1847. Genomic and structural differences among some of the newly described HRVs are explored in this article.
11. Lau SK, Yip CC, Tsoi HW, et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol 2007; 45:3655-3664. This is another large series in which molecular techniques were used to detect new strains of HRV.
12. Briese T, Renwick N, Venter M, et al. Global distribution of novel rhinovirus genotype. Emerg Infect Dis 2008; 14:944-947.
13. Jartti T, Lee WM, Pappas T, et al. Serial viral infections in infants with recurrent respiratory illnesses. Eur Respir J 2008; 32:314-320.
14. Peltola V, Waris M, Osterback R, et al. Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis 2008; 197: 382-389. This is an excellent study that defines HRV detection in healthy and sick individuals within families and identifies patterns of viral transmission.
15. Alper CM, Doyle WJ, Winther B, Owen HJ. Upper respiratory virus detection without parent-reported illness in children is virus-specific. J Clin Virol 2008; 43:120-122.
16. McFadden ER Jr, Pichurko BM, Bowman HF, et al. Thermal mapping of the airways in humans. J Appl Physiol 1985; 58:564-570.
17. Mosser AG, Vrtis R, Burchell L, et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med 2005; 171: 645-651.
18. Gern JE, Galagan DM, Jarjour NN, et al. Detection of rhinovirus RNA in lower airway cells during experimentally-induced infection. Am J Respir Crit Care Med 1997; 155: 1159-1161.
19. Papadopoulos NG, Bates PJ, Bardin PG, et al. Rhinoviruses infect the lower airways. J Infect Dis 2000; 181: 1875-1884.
20. Tsolia MN, Psarras S, Bossios A, et al. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis 2004; 39: 681 - 686.
21. Lemanske RF Jr. The childhood origins of asthma (COAST) study. Pediatr Allergy Immunol 2002; 13 (Suppl 15): 38-43.
22. Martinez FD, Wright AL, Taussig LM, et al., Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332: 133-138.
23. Palmer LJ, Rye PJ, Gibson NA, et al. Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age. Am J Respir Crit Care Med 2001; 163: 37-42.
24. Singh AM, Moore PE, Gern JE, et al. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. Am J Respir Crit Care Med 2007; 175: 108-119.
25. Helminen M, Nuolivirta K, Virta M, et al. IL-10 gene polymorphism at -1082 A/G is associated with severe rhinovirus bronchiolitis in infants. Pediatr Pulmonol 2008; 43: 391 - 395.
26. Reijonen TM, Kotaniemi-Syrjanen A, Korhonen K, Korppi M. Predictors of asthma three years after hospital admission for wheezing in infancy. Pediatrics 2000; 106: 1406-1412.
27. Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, et at. Rhinovirus-induced wheezing in infancy: the first sign of childhood asthma? J Allergy Clin Immunol 2003; 111:66-71.
28. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178: 667-672. In a birth cohort including families with a parental history of allergies or asthma, HRV infections in infancy were the strongest predictor of asthma at 6 years of age. The effects of allergic sensitization and HRV-induced wheezing were additive in terms of asthma risk.
29. Kusel MM, de Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119: 1105-1110. In this high-risk birth cohort, early wheezing infections with HRV and RSV were associated with increased risk of subsequent asthma. This effect was driven by children with the onset of allergic sensitization before the age of 2 years.
30. American Thoracic Society ad hoc Statement Committee. Mechanisms and limits of induced postnatal lung growth. Am J Respir Crit Care Med 2004; 170: 319-343.
31. Lopez-Souza N, Dolganov G, Dubin R, et al. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am J Physiol Lung Cell Mol Physiol 2004; 2861373-L381.
32. Jakiela B, Brockman-Schneider R, Amineva S, et al. Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection. Am J Respir Cell Mol Biol 2008; 38:517-523.
33. Arruda E, Boyle TR, Winther B, et al. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J Infect Dis 1995; 171: 1329-1333.
34. Mosser AG, Brockman-Schneider RA, Amineva SP, et-al. Similar frequency of rhinovirus-infectable cells in upper and lower airway epithelium. J Infect Dis 2002; 185:734-743.
35. Edwards MR, Slater L, Johnston SL. Signalling pathways mediating type I interferon gene expression. Microbes Infect 2007; 9: 1245-1251.
36. Edwards MR, Hewson CA, Laza-Stanca V, et al. Protein kinase R, IkappaB kinase-beta and NF-kappaB are required for human rhinovirus induced proinflammatory cytokine production in bronchial epithelial cells. Mol Immunol 2007; 44: 1587-1597.
37. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-738.
38. Gern JE, French DA, Grindle KA, et al. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. Am J Respir Cell Mol Biol 2003; 28: 731-737.
39. Hall DJ, Bates ME, Guar L, et al. The role of p38 MAPK in rhinovirus-induced monocyte chemoattractant protein-1 production by monocytic-lineage cells. J Immunol 2005; 174:8056-8063.
40. Korpi-Steiner NL, Bates ME, Lee WM, et al. Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation. J Leukoc Biol 2006; 80: 1364-1374.
41. Papadopoulos NG, Stanciu LA, Papi A, et al. A defective type 1 response to rhinovirus in atopic asthma. Thorax 2002; 57:328-332.
42. Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006; 12:1023-1026.
43. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201: 937-947.
44. Copenhaver CC, Gern JE, Li Z, et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med 2004; 170: 175-180.
45. Gern JE, Brooks GD, Meyer P, et al. Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol 2006; 117: 72-78.
46. Stern DA, Guerra S, Halonen M, et al. Low IFN-gamma production in the first year of life as a predictor of wheeze during childhood. J Allergy Clin Immunol 2007; 120: 835-841. This study evaluated interferon responses at 9 months of age, and compared the immunologic results with an exceptionally long period of follow-up, and multiple wheezing phenotypes.
47. Cardell LO, Agusti C, Takeyama K, et al. LTB(4)-induced nasal gland serous cell secretion mediated by neutrophil elastase. Am J Respir Crit Care Med 1999; 160:411-414.
48. Davoine F, Cao M, Wu Y, et al. Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells. J Allergy Clin Immunol 2008; 122:69-77; 77.
49. Rakes GP, Arruda E, Ingram JM, et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care: IgE and eosinophil analyses. Am J Respir Crit Care Med 1999; 159: 785-790.
50. Lee CG, Yoon HJ, Zhu Z, et al. Respiratory syncytial virus stimulation of vascular endothelial cell growth factor/vascular permeability factor. Am J Respir Cell Mol Biol 2000; 23: 662-669.
51. Leigh R, Oyelusi W, Wiehler S, et al. Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol 2008; 121: 1238-1245. HRV stimulated epithelial cells to produce VEGF, amphiregulin, and activin A, all of which have been linked to airway remodeling in asthma.
52. Sanders SP. Asthma, viruses, and nitric oxide. Proc Soc Exp Biol Med 1999; 220: 123-132.
53. Uhl EW, Castleman WL, Sorkness RL, et al. Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-β, expression in Brown Norway rats. Am J Respir Crit Care Med 1996; 154: 1834-1842.
54. Dosanjh A. Transforming growth factor-beta expression induced by rhinovirus infection in respiratory epithelial cells. Acta Biochim Biophys Sin (Shanghai) 2006; 38:911-914.
55. Dosanjh A, Rednam S, Martin M. Respiratory syncytial virus augments production of fibroblast growth factor basic in vitro: implications for a possible mechanism of prolonged wheezing after infection. Pediatr Allergy Immunol 2003; 14: 437-440.
56. Tortorolo L, Langer A, Polidori G, et al. Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med 2005; 172: 233-237.
57. Bartlett NW, Walton RP, Edwards MR, et al. Mouse models of rhinovirusinduced disease and exacerbation of allergic airway inflammation. Nat Med 2008; 14: 199-204. This group has developed a mouse model of HRV infection. Although viral replication is limited in the mouse, many of the inflammatory responses closely resemble those associated with common cold, and interactions with allergic inflammatory responses were demonstrated.
58. Newcomb DC, Sajjan US, Nagarkar DR, et al. Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am J Respir Crit Care Med 2008; 177:1111-1121. This is another demonstration of a potentially useful mouse model of HRV infection, with a nice demonstration of inflammatory responses that are similar to those in humans.
59. Brockman-Schneider RA, Amineva SP, Bulat MV, Gern JE. Serial culture of murine primary airway epithelial cells and ex vivo replication of human rhinoviruses. J Immunol Methods 2008 [Epub ahead of print].
60. Simoes EA, Groothuis JR, Carbonell-Estrany X, et al. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr 2007; 151: 34-42. Although this study was not randomized, palivizumab treatment reduced the incidence of recurrent wheezing by half.
61. Lehtinen P, Ruohola A, Vanto T, et al. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol 2007; 119: 570-575. Children hospitalized with wheezing caused by HRV, but not by RSV, had reduced risk of recurrent wheezing if they were treated with oral prednisolone.